Rebyota
(Donor Human Stool)Ferring Pharmaceuticals Inc.
Usage: REBYOTA is indicated for preventing the recurrence of Clostridioides difficile infection (CDI) in adults aged 18 and older after antibiotic treatment for recurrent CDI. It is not intended for the treatment of CDI.